Unusually Long Survival from Diagnosis (More Than Three Years to More Than 29 Years) in 27 Glioblastoma Patients Treated with Antineoplastons in Phase II Studies
Burzynski SR, Burzynski GS, Janicki TJ, Siwiec RJ, Beenken SW. Unusually Long Survival
from Diagnosis (More Than Three Years to More Than 29 Years) in 27 Glioblastoma Patients Treated with
Antineoplastons in Phase II Studies. Neurol Neurosci. 2025;6(7):036.
